The REZA BAND applies slight pressure to the neck to reduce laryngopharyngeal reflux symptoms. In clinical trials, 86 percent of patients were found to have significant symptom reduction after two weeks, according to the report.
Reza Shaker, MD, chief of gastroenterology and hepatology at Froedtert & The Medical College of Wisconsin in Milwaukee, is one of the founders of Somna Therapeutics.
More articles on gastroenterology:
26 gastroenterologists making headlines – March 10, 2015
Exact Sciences, Ironwood Pharmaceuticals partner for promotion of Cologuard
Gastroenterology technology company to know: Exalenz Bioscience
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.